Revision as of 20:52, 25 December 2024 editJesswade88 (talk | contribs)Autopatrolled, Extended confirmed users, New page reviewers, Pending changes reviewers7,654 edits STARTED PAGETag: Visual edit | Revision as of 04:53, 26 December 2024 edit undoChris the speller (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers866,928 editsm capTag: AWBNext edit → | ||
Line 8: | Line 8: | ||
}} | }} | ||
'''Dana Gelb Safran''' is an American public health expert, |
'''Dana Gelb Safran''' is an American public health expert, president and ] of the ]. She looks to use science to improve the quality, outcomes and affordability of care. She was elected to the ] in 2024. | ||
== Early life and education == | == Early life and education == | ||
Line 16: | Line 16: | ||
She spent ten years at the ], where she developed the ].<ref name=":0" /> Working with ], ] and ], Safran developed initiatives to improve the health outcomes and care experiences of patients.<ref name=":1" /> | She spent ten years at the ], where she developed the ].<ref name=":0" /> Working with ], ] and ], Safran developed initiatives to improve the health outcomes and care experiences of patients.<ref name=":1" /> | ||
In 2021 Safran was elected |
In 2021 Safran was elected president and ] of the ].<ref name=":1" /><ref>{{Cite web |last=Radulovic |first=Jon |date=2021-07-30 |title=NQF Board of Directors Appoints Dr. Dana Gelb Safran as New President and CEO |url=https://ehospice.com/usa_posts/nqf-appoints-ceo/ |access-date=2024-12-25 |language=en-US}}</ref> The NQF look to evaluate the scientific and clinical merits of healthcare quality measures, and advise Medicare and Medicaid.<ref>{{Cite web |last=Gibbs |first=Vanessa |date=2022-02-09 |title=Take Five Interview with Dana Gelb Safran, ScM and ScD |url=https://www.njhcqi.org/take-five-interview-2-10-2022/ |access-date=2024-12-25 |website=NJHCQI |language=en-US}}</ref> | ||
In 2024 Safran was elected to the ].<ref>{{Cite web |title=NQF: NQF President & CEO Dana Gelb Safran Elected to National Academy of Medicine |url=https://www.qualityforum.org/News_And_Resources/Press_Releases/2024/NQF_President___CEO_Dana_Gelb_Safran_Elected_to_National_Academy_of_Medicine.aspx |access-date=2024-12-25 |website=www.qualityforum.org}}</ref> | In 2024 Safran was elected to the ].<ref>{{Cite web |title=NQF: NQF President & CEO Dana Gelb Safran Elected to National Academy of Medicine |url=https://www.qualityforum.org/News_And_Resources/Press_Releases/2024/NQF_President___CEO_Dana_Gelb_Safran_Elected_to_National_Academy_of_Medicine.aspx |access-date=2024-12-25 |website=www.qualityforum.org}}</ref> |
Revision as of 04:53, 26 December 2024
Dana Gelb Safran | |
---|---|
Alma mater | Harvard T.H. Chan School of Public Health Wesleyan University |
Scientific career | |
Institutions | National Quality Forum Tufts University School of Medicine |
Thesis | Managing chronic conditions : patient, provider and system (1992) |
Dana Gelb Safran is an American public health expert, president and chief executive officer of the National Quality Forum. She looks to use science to improve the quality, outcomes and affordability of care. She was elected to the National Academy of Medicine in 2024.
Early life and education
Safran studied biology at Wesleyan University. She was a doctoral researcher at the Harvard T.H. Chan School of Public Health. Her PhD explored how patients, providers and healthcare systems can better manage chronic conditions.
Research and career
She spent ten years at the Blue Cross Blue Shield of Massachusetts, where she developed the alternative quality contract. Working with Amazon, Berkshire Hathaway and JPMorgan Chase, Safran developed initiatives to improve the health outcomes and care experiences of patients.
In 2021 Safran was elected president and chief executive officer of the National Quality Forum. The NQF look to evaluate the scientific and clinical merits of healthcare quality measures, and advise Medicare and Medicaid.
In 2024 Safran was elected to the National Academy of Medicine.
Select publications
- T. O. Tengs; M. E. Adams; J. S. Pliskin; D. G. Safran; J. E. Siegel; M. C. Weinstein; J. D. Graham (1 June 1995). "Five-hundred life-saving interventions and their cost-effectiveness". Risk Analysis. 15 (3): 369–390. doi:10.1111/J.1539-6924.1995.TB00330.X. ISSN 1539-6924. PMID 7604170. Wikidata Q34299363.
- D G Safran; D A Taira; W H Rogers; M Kosinski; J E Ware; A R Tarlov (1 September 1998). "Linking primary care performance to outcomes of care". Journal of Family Practice. 47 (3): 213–220. ISSN 0094-3509. PMID 9752374. S2CID 6884141. Wikidata Q77346017.
- Karen Luxford; Dana Gelb Safran; Tom Delbanco (16 May 2011). "Promoting patient-centered care: a qualitative study of facilitators and barriers in healthcare organizations with a reputation for improving the patient experience" (PDF). International Journal for Quality in Health Care. 23 (5): 510–515. doi:10.1093/INTQHC/MZR024. ISSN 1353-4505. PMID 21586433. Wikidata Q51867051.
References
- ^ "Dana Gelb Safran | Harvard T.H. Chan School of Public Health". Retrieved 2024-12-25.
- ^ "NQF: Dana Gelb Safran". www.qualityforum.org. Retrieved 2024-12-25.
- search.worldcat.org https://search.worldcat.org/en/title/83835635. Retrieved 2024-12-25.
{{cite web}}
: Missing or empty|title=
(help) - Radulovic, Jon (2021-07-30). "NQF Board of Directors Appoints Dr. Dana Gelb Safran as New President and CEO". Retrieved 2024-12-25.
- Gibbs, Vanessa (2022-02-09). "Take Five Interview with Dana Gelb Safran, ScM and ScD". NJHCQI. Retrieved 2024-12-25.
- "NQF: NQF President & CEO Dana Gelb Safran Elected to National Academy of Medicine". www.qualityforum.org. Retrieved 2024-12-25.